The climate crisis is the defining challenge of our generation. Its impact is evident in the rising global temperature causing increasingly frequent wildfires, floods and droughts. Greenhouse gases caused by human activity are the main drivers of climate change, so we are taking action to limit and offset ramarketing’s contribution and footprint.
In 2022, ramarketing put the foundations in place for our ESG initiative and began to shape a strategy. Since publishing our first Net Zero report in 2023, we have continued to strengthen our approach to environmental, social and governance responsibility. In 2024, we expanded the quality and coverage of our carbon reporting, embedded ESG considerations more firmly across our operations, and progressed from establishing a baseline to taking targeted action in the areas where we have the greatest influence.
Our mission is to do the right thing by contributing to a more sustainable, responsible and inclusive world, starting at a grassroots level.
scope carbon emissions reduction by 2030 in line with the 1.5 °C target set within the Paris Agreement
renewable energy use in our office spaces by 2027
sustainable and/or local suppliers by 2028
In 2024, we formalized our Net Zero strategy to move from measurement to action. Our approach focuses on the areas where we can make the most meaningful impact across our operations and value chain, supported by clear objectives, accountability and ongoing monitoring.
As a growth partner to the life sciences sector, we believe our own ESG approach should reflect the increasing expectations placed on the industry as a whole.
Beyond our environmental impact, we know we have a role to play in the broader communities where we operate and we give back as much as we can. Every year, we nominate 3-5 charities that we support with fundraising initiatives led by our people.
Our annual net-zero reports outline how ramarketing contributes to limiting the effects of climate change.
We measure and disclose our carbon footprint annually, covering Scopes 1, 2, and the majority of Scope 3 emissions. Since our first reporting year, we have continued to improve the breadth and quality of our data to support more accurate reporting, better year-on-year comparison and more informed decision-making.
Direct emissions coming from factors such as company vehicles, buildings,
and facilities: 11.2 (tCO2e)
Indirect emissions consisting of our purchased electricity (and steam, heating, and cooling) for business use: 3.5 (tCO2e)
Upstream activities such as commuting, business travel, transportation from suppliers, and purchased goods and services: 281.4 (tCO2e)
In 2024, our absolute emissions increased compared to previous years, largely due to business growth and international expansion. However, when measured against headcount and revenue, our carbon intensity continued to decline, reinforcing our commitment to managing environmental impact responsibly as we scale.
The good news is:
During 2024, we increased employee engagement on sustainability, delivered targeted training, and strengthened internal policies to support lower-carbon choices in day-to-day work. We also further embedded ESG considerations into business planning and decision-making, ensuring that climate-related risks and opportunities are considered alongside commercial and operational priorities.
As we continue to measure more of our downstream impact, we aim to work more closely with clients to support responsible growth, informed decision-making, and long-term sustainability across the life sciences sector. We are committed to improving sustainability across our supply chain by strengthening supplier engagement, improving data quality, and embedding sustainability considerations into procurement decisions.
Our ESG journey is ongoing. We are committed to measuring what matters, improving year on year, and working collaboratively with our people, partners, and clients to support a more sustainable, resilient, and inclusive future for our industry.
Related news, insight and opinion